One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Issue Highlights page
doi : 10.1016/S0360-3016(21)02657-2
Volume 111, Issue 3, 1 November 2021, Pages A9-A10
Hypofractionated Irradiation and Immune Modulation Therapies: Let's Work Together!
Sean S.ParkMD, PhD*MarjanBoermaPhD†
doi : 10.1016/j.ijrobp.2021.06.002
Volume 111, Issue 3, 1 November 2021, Pages 589-591
Primary Mediastinal B-Cell Lymphoma: The Role of Consolidative Radiation for a “Terrible” Lymphoma
GarrettAndersonAshwinShindeMD
doi : 10.1016/j.ijrobp.2020.02.641
Volume 111, Issue 3, 1 November 2021, Pages 592-593
To Radiate or Not to Radiate? Implications of PET Biomarkers in Primary Mediastinal B-cell Lymphoma
RyanKrausMDRandaTaoMD
doi : 10.1016/j.ijrobp.2020.03.048
Volume 111, Issue 3, 1 November 2021, Page 594
Biopsy, as Deauville May Deceive
Mohammad K.KhanMD, PhDWaleed F.MouradMD
doi : 10.1016/j.ijrobp.2020.03.047
Volume 111, Issue 3, 1 November 2021, Pages 594-595
PET/CT Responses in Primary Mediastinal Large B-Cell Lymphoma: What’s Negative?
John P.PlastarasMD, PhDJakubSvobodaMD
doi : 10.1016/j.ijrobp.2020.03.044
Volume 111, Issue 3, 1 November 2021, Pages 595-596
Carbon Ion Radiation Therapy: One Decade of Research and Clinical Experience at Heidelberg Ion Beam Therapy Center
TanjaEichkornMD?†‡§LailaKönigMD?†‡§ThomasHeldMD?†‡§PatrickNaumannMD?†‡§SemiHarrabiMD?†‡§MalteEllerbrockPhD§KlausHerfarthMD?†‡§ThomasHabererPhD§JürgenDebusMD, PhD,?†‡§?¶
doi : 10.1016/j.ijrobp.2021.05.131
Volume 111, Issue 3, 1 November 2021, Pages 597-609
Practice Consolidation Among U.S. Radiation Oncologists Over Time
MichaelMilliganMD, MBA?†‡MeganHansenBA, BS§Daniel W.KimMD, MBA?†‡E. JohnOravPhD?#Jose F.FigueroaMD, MPH??††Miranda B.LamMD, MBA†‡
doi : 10.1016/j.ijrobp.2021.06.009
Volume 111, Issue 3, 1 November 2021, Pages 610-618
Does Bigger Practice Size Mean Better for Patients and Providers?
Andrew C.HooverMD*AmarRewariMD, MBA†Ronald C.ChenMD, MPH*
doi : 10.1016/j.ijrobp.2021.07.001
Volume 111, Issue 3, 1 November 2021, Pages 619-621
United States Radiation Oncology Fellowship Growth From 2010 to 2020
MuditChowdharyMD?SinéadO'BryantBS†Gabrielle W.PetersMD‡NehaVapiwalaMD§OsamaMohamadMD, PhD?Trevor J.RoyceMD, MS, MPH¶#
doi : 10.1016/j.ijrobp.2021.06.022
Volume 111, Issue 3, 1 November 2021, Pages 622-626
The Holman Research Pathway in Radiation Oncology: 2010 to 2019
Kunal K.SindhuMDJared P.RowleyMDWilliam H.SmithMDAnthony D.NehlsenMDAndrew W.SmithMDEric J.LehrerMD, MSStanislavLazarevMDKenneth E.RosenzweigMDMichaelBucksteinMD, PhD
doi : 10.1016/j.ijrobp.2021.06.020
Volume 111, Issue 3, 1 November 2021, Pages 627-637
There has not been an assessment of the Holman Research Pathway (HRP) in radiation oncology (RO) in nearly 10 years. In this study, we sought to review the demographic characteristics, research productivity during and after residency, job placements, and National Institutes of Health (NIH) grant funding of RO residents who completed the HRP in the modern era.
Residents-as-Teachers Curriculum for Radiation Oncology: A Targeted Needs Assessment
LisaNiMDHoratio R.ThomasMD, MScDavid R.RaleighMD, PhDLauren C.BoretaMDCatherine C.ParkMDSteve E.BraunsteinMD, PhD
doi : 10.1016/j.ijrobp.2021.06.024
Volume 111, Issue 3, 1 November 2021, Pages 638-642
The Fallacy of the Consultation and Informed Consent Process in Radiation Oncology Through the Lens of Prostate Cancer
Ronald D.EnnisMD*NehaVapiwalaMD†
doi : 10.1016/j.ijrobp.2021.06.018
Volume 111, Issue 3, 1 November 2021, Pages 643-646
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects
YunHuPhD*SébastienParisPhD†HampartsoumBarsoumianPhD*Chike O.AbanaMD, PhD*KewenHeMD?‡MarkWasleyBS*Ahmed I.YounesMD§FatemehMasrorpourMS*DaweiChenMD, PhD‡LiangpengYangPhD*Joe DanDunnPhD?JieZhangMD*SaumilGandhiMD, PhD*Quynh-NhuNguyenMD*Maria AngelicaCortezPhD*JamesWelshMD*
doi : 10.1016/j.ijrobp.2021.06.041
Volume 111, Issue 3, 1 November 2021, Pages 647-657
Modulation of Neuroinflammation by Low-Dose Radiation Therapy in an Animal Model of Alzheimer's Disease
Eun-JeongYangPhD?†HyunjuKimPhD?†YunjungChoiBS?Hak JaeKimMD, PhD‡§||Jin HoKimMD, PhD‡JeongminYoonPhD¶#Young-SeokSeoMD, PhD??Hye-SunKimPhD?†††
doi : 10.1016/j.ijrobp.2021.06.012
Volume 111, Issue 3, 1 November 2021, Pages 658-670
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies
DarrenZuroMS*Srideshikan SargurMadabushiPhD*JamisonBrooksBS*Bihong T.ChenMD, PhD†JanagamaGoudPhD*AmandeepSalhotraMD‡Joo Y.SongMD§Liliana EchavarriaParraBS*AntonioPieriniMD, PhD||James F.SanchezPhD¶AnthonySteinMD‡Monzr AlMalkiMD‡MarcinKortylewskiPhD#Jeffrey Y.C.WongMD*ParhamAlaeiPhD??JerryFroelichMD††GuyStormeMD, PhD‡‡Susanta K.HuiPhD?¶??
doi : 10.1016/j.ijrobp.2021.06.001
Volume 111, Issue 3, 1 November 2021, Pages 671-683
Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer
Grete MayEngesethMSc*?>†‡RenjieHePhD*DraganMirkovicPhD§PabloYepesPhD?Abdallah Sherif RadwanMohamedMD, MSc*SonjaStiebMD*Clifton DaveFullerPhD*RichardWuMSc*XiadongZhangPhD*Liv BolstadHysingPhD†#Helge Egil SeimePettersenPhD†Camilla HanquistStokkevågPhD†#RadheMohanPhD§Steven JayFrankMD*Gary BrandonGunnMD*
doi : 10.1016/j.ijrobp.2021.06.016
Volume 111, Issue 3, 1 November 2021, Pages 684-692
Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model
Mohammad U.ZahidPhD*NuverahMohsinBS*†Abdallah S.R.MohamedMD‡Jimmy J.CaudellMD, PhD§Louis B.HarrisonMD§Clifton D.FullerMD, PhD‡Eduardo G.MorosPhD§HeikoEnderlingPhD*§
doi : 10.1016/j.ijrobp.2021.05.132
Volume 111, Issue 3, 1 November 2021, Pages 693-704
Wide-Scale Clinical Implementation of Knowledge-Based Planning: An Investigation of Workforce Efficiency, Need for Post-automation Refinement, and Data-Driven Model Maintenance
RobertKaderkaPhD*Sebastian J.HildPhD*Victoria N.BryBA†MarielCornellCMD*Xenia J.RayPhD*James D.MurphyMD, MSc*Todd F.AtwoodPhD*Kevin L.MoorePhD*
doi : 10.1016/j.ijrobp.2021.06.028
Volume 111, Issue 3, 1 November 2021, Pages 705-715
Effects of Exercise During Radiation Therapy on Physical Function and Treatment-Related Side Effects in Men With Prostate Cancer: A Systematic Review and Meta-Analysis
OliverSchumacherMSc*†HaoLuoMEd?†Dennis R.TaaffePhD, DSc, MPH*†Daniel A.GalvãoPhD*†ColinTangMBBS, FRANZCR*‡RaphaelCheeMBBS, FRANZCR*§NigelSpryMBBS, PhD, FRANZCR*?Robert U.NewtonPhD, DSc*†
doi : 10.1016/j.ijrobp.2021.06.034
Volume 111, Issue 3, 1 November 2021, Pages 716-731
Optimizing Treatment in Intermediate-Risk Prostate Cancer: Secondary Analysis of a Randomized Phase 3 Trial
AbdenourNabidMD, FRCPC?NathalieCarrierMSc†EricVigneaultMD‡ThuVan NguyenMD§PeterVavassisMD?Marc-AndréBrassardMD¶BorisBahoricMD#RobertArchambaultMD??FrançoisVincentMD††RedouaneBettaharMD‡‡DerekWilkeMD§§LuisSouhamiMD, FASTRO??
doi : 10.1016/j.ijrobp.2021.04.013
Volume 111, Issue 3, 1 November 2021, Pages 732-740
Recommendations and Clinical Validation of Inguinal Clinical Target Volume Delineation in Penile Cancer
RishiMittalMDRahulKrishnatryMDPriyamvadaMaitreMDVedangMurthyMD
doi : 10.1016/j.ijrobp.2021.06.027
Volume 111, Issue 3, 1 November 2021, Pages 741-753
Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial
MiaSalansMD, MAS?Michelle D.TibbsMD, MAS*Minh-PhuongHuynh-LeMD, MAS*AnthonyYipMD, MAS?KathrynTringaleMD, MAS†RoshanKarunamuniPhD*RonghuiXuPhD‡AnnyReyesMA, MS§Anna ChristinaMacariMS§TonyaPan-WeiszPhD§Carrie R.McDonaldPhD*§Jona A.Hattangadi-GluthMD*
doi : 10.1016/j.ijrobp.2021.05.134
Volume 111, Issue 3, 1 November 2021, Pages 754-763
Preoperative Radiosurgery for Resected Brain Metastases: The PROPS-BM Multicenter Cohort Study
Roshan S.PrabhuMD, MS?†ReshikaDhakalMD?Zachary K.VaslowMD‡TuDanMD§Mark V.MishraMD?Erin S.MurphyMD¶Toral R.PatelMD#Anthony L.AsherMD???KailinYangMD, PhD¶Matthew A.ManningMD‡Joseph D.SternMD‡??Ankur R.PatelMD††ZabiWardakMD§Graeme F.WoodworthMD‡‡Samuel T.ChaoMD¶AlirezaMohammadiMD§§Stuart H.BurriMD?†
doi : 10.1016/j.ijrobp.2021.05.124
Volume 111, Issue 3, 1 November 2021, Pages 764-772
Evaluation of Long-Term Outcomes and Toxicity After Stereotactic Phosphorus-32–Based Intracavitary Brachytherapy in Patients With Cystic Craniopharyngioma
XinYuMD, PhD*Sebastian M.ChristMD, PhD†RuiLiuMD*YamingWangMD*ChenhaoHuMD*BoFengPhD‡AnandMahadevanMD§Ekkehard M.KasperMD, PhD§?
doi : 10.1016/j.ijrobp.2021.05.123
Volume 111, Issue 3, 1 November 2021, Pages 773-784
The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes After Stereotactic Radiosurgery in Patients With Unruptured Cerebral Arteriovenous Malformations
Huai-CheYangMD, PhD*†‡Hsiu-MeiWuMD†§Syu-JyunPengPhD?Cheng-ChiaLeeMD, PhD*†‡Yu-WeiChenMS‡Ai SeonKuanMD, PhD‡§§Cheng-YingShiauMD†#I-ChunLaiMD†#Wan-YuoGuoMD, PhD†§Chung-JungLinMD†§David Hung-ChiPanMD†‡??Wen-YuhChungMD†‡Kang-DuLiuMD?‡Yung-YangLinMD, PhD*†††‡‡
doi : 10.1016/j.ijrobp.2021.05.135
Volume 111, Issue 3, 1 November 2021, Pages 785-793
Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation
TomoyaYokotaMD, PhD*SadamotoZendaMD, PhD†IchiroOtaMD, PhD‡TomokoYamazakiMD, PhD§TakuhiroYamaguchiPhD?TakenoriOgawaMD, PhD¶HiroyukiTachibanaMD#TakashiToshiyasuMD??AkihiroHommaMD††TempeiMiyajiMS‡‡TomoeMashiko§§SatoshiHamauchiMD*KunikoTominaga??ShinobuIshii†YuiOtani¶¶NorikoOrito##YosukeUchitomiMD???
doi : 10.1016/j.ijrobp.2021.05.133
Volume 111, Issue 3, 1 November 2021, Pages 794-803
Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer With Brain Metastases
FanYuMD?†JianjiaoNiMD?†WanqinZengMD‡YueZhouMD?†TiantianGuoMD?†YaZengMD?†YangZhaoMD?†ShuyanLiMD?†YidaLiMD?†XiYangMD?†LiqingZouMD?†ShengpingWangMD†§QuanLiuMD†§YuanLiMD†?LiChuMD?†XiaoChuMD?†LuxiYeMD?†WenYuMD‡ZhengfeiZhuMD, PhD?†¶
doi : 10.1016/j.ijrobp.2021.05.125
Volume 111, Issue 3, 1 November 2021, Pages 804-815
Prognostic Implications of MRI-Detected EMVI and Tumor Deposits and Their Response to Neoadjuvant Therapy in cT3 and cT4 Rectal Cancer
Dennis P.SchaapBSc*Eva L.K.VoogtMD*Jacobus W.A.BurgerPhD*Jeltsje S.CnossenPhD†Geert-Jan M.CreemersPhD‡Inekevan LijnschotenPhD§Grard A.P.NieuwenhuijzenPhD*Harm J.T.RuttenPhD*?Alette W.Daniels-GooszenPhD¶JoostNederendPhD¶MirandaKustersPhD#
doi : 10.1016/j.ijrobp.2021.06.013
Volume 111, Issue 3, 1 November 2021, Pages 816-825
Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes
UmeshMahantshettyMD, DNB, DMRT?†LavanyaGurramMD?SabheenBushraMD‡YogeshGhadiDipRP*DheeraAravindakshanDipRP*JohnPaulDipRP*VinodHandeBHMS*AvinashPilarMD*SupriyaChopraMD§JayaGhoshMD, DM?T.S.ShylasreeMS, FRCOG¶PalakPopatMD#NileshSableMD#AmitaMaheswariMS¶SudeepGuptaMD, DM?
doi : 10.1016/j.ijrobp.2021.06.014
Volume 111, Issue 3, 1 November 2021, Pages 826-834
Radiation Recall Phenomenon Following COVID-19 Vaccination
RachelStewartMB BSLachlanMcDowellMB, BS
doi : 10.1016/j.ijrobp.2021.06.023
Volume 111, Issue 3, 1 November 2021, Pages 835-836
For the Love of Radiation Oncology: A Resident Trainee Perspective
AlexanderYaneyMDNikolMladkovaMD, PhD, MPHSachin R.JhawarMD
doi : 10.1016/j.ijrobp.2021.06.042
Volume 111, Issue 3, 1 November 2021, Page 836
In Regard to Choudhury et al.
Varun KumarChowdhryMD
doi : 10.1016/j.ijrobp.2021.06.043
Volume 111, Issue 3, 1 November 2021, Page 837
In Regard to Hathout et al.
CemOnalMD12EzgiOymakMDGulerYavasMD
doi : 10.1016/j.ijrobp.2021.06.044
Volume 111, Issue 3, 1 November 2021, Pages 837-838
In reply to Onal et al.
LaraHathoutMDMohamed A.ElshaikhMDKevin V.AlbuquerqueMD
doi : 10.1016/j.ijrobp.2021.06.045
Volume 111, Issue 3, 1 November 2021, Pages 838-839
